{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:38:21Z","timestamp":1793324301144,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd014808","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000}}],"reference-count":83,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014808.pub2","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:15:51Z","timestamp":1762992951000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Colchicine for the secondary prevention of cardiovascular events"],"prefix":"10.1002","volume":"2025","author":[{"given":"Fahim","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology; University Digestive Health Care Center Basel \u2013 Clarunis, Switzerland; Basel Switzerland"},{"name":"Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Ebrahimi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine B; University Medicine Greifswald; Greifswald Germany"},{"name":"Zentrum f\u00fcr Kardiologie; Heart Clinic Pratteln; Pratteln Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Beer","sequence":"additional","affiliation":[{"name":"Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB); University of Basel and University Hospital Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof Manuel","family":"Sch\u00f6nenberger","sequence":"additional","affiliation":[{"name":"CLEAR Methods Center, Division of Clinical Epidemiology, Department of Clinical Research; University Hospital Basel; Basel Switzerland"},{"name":"University of Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Ewald","sequence":"additional","affiliation":[{"name":"University Medical Library; University of Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Briel","sequence":"additional","affiliation":[{"name":"CLEAR Methods Center, Division of Clinical Epidemiology, Department of Clinical Research; University Hospital Basel; Basel Switzerland"},{"name":"University of Basel; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Janiaud","sequence":"additional","affiliation":[{"name":"Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB); University of Basel and University Hospital Basel; Basel Switzerland"},{"name":"Department of Clinical Research, Faculty of Medicine; University of Bern; Bern Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Hirt","sequence":"additional","affiliation":[{"name":"Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB); University of Basel and University Hospital Basel; Basel Switzerland"},{"name":"Department of Health; Eastern Switzerland University of Applied Sciences; St Gallen Switzerland"},{"name":"Institute of Health and Nursing Science, Medical Faculty; Martin Luther University Halle-Wittenberg; Halle (Saale) Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars G","family":"Hemkens","sequence":"additional","affiliation":[{"name":"Department of Clinical Research, Faculty of Medicine; University of Bern; Bern Switzerland"},{"name":"Meta-Research Innovation Center at Stanford (METRICS); Stanford University; Stanford CA USA"},{"name":"Pragmatic Evidence Lab, Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB); University of Basel and University Hospital Basel; Basel Switzerland"},{"name":"Meta-Research Innovation Center Berlin (METRIC-B); Berlin Institute of Health; Berlin Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"10.1002\/14651858.CD014808.pub2-BIB0001|cit1","unstructured":"World Health Organization The top 10 causes of death Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death 2024"},{"issue":"25","key":"10.1002\/14651858.CD014808.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019","volume":"76","author":"Roth","year":"2020","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0003|cit3","unstructured":"World Health Organization Cardiovascular diseases (CVDs) Available at https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds) 2025"},{"issue":"10258","key":"10.1002\/14651858.CD014808.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"10384","key":"10.1002\/14651858.CD014808.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"issue":"46","key":"10.1002\/14651858.CD014808.pub2-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1093\/eurheartj\/ehy633","article-title":"Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions","volume":"39","author":"Kalkman","year":"2018","journal-title":"European Heart Journal"},{"issue":"7855","key":"10.1002\/14651858.CD014808.pub2-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1002\/14651858.CD014808.pub2-BIB0008|cit8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1001\/jamacardio.2022.3926","article-title":"Fundamental pathobiology of coronary atherosclerosis and clinical implications for chronic ischemic heart disease management-the plaque hypothesis: a narrative review","volume":"8","author":"Stone","year":"2023","journal-title":"JAMA Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD014808.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.106.652081","article-title":"The inflammatory hypothesis","volume":"114","author":"Blankenberg","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1002\/14651858.CD014808.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11886-020-01439-2","article-title":"Update on the inflammatory hypothesis of coronary artery disease","volume":"23","author":"Boland","year":"2021","journal-title":"Current Cardiology Reports"},{"issue":"7862","key":"10.1002\/14651858.CD014808.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/d41586-021-01453-6","article-title":"Inflammation in heart disease: do researchers know enough?","volume":"594","author":"DeWeerdt","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD014808.pub2-BIB0012|cit12","first-page":"22","article-title":"Critical roles of inflammation in atherosclerosis","volume":"73","author":"Moriya","year":"2019","journal-title":"Anticoagulants and Bleeding"},{"issue":"9709","key":"10.1002\/14651858.CD014808.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"The Emerging Risk Factors Collaboration","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1002\/14651858.CD014808.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumabfor atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD014808.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD014808.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jacc.2023.05.055","article-title":"Low-dose colchicine for secondary prevention of coronary artery disease: JACC review topic of the week","volume":"82","author":"Nelson","year":"2023","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD014808.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint, Bone, Spine"},{"issue":"10","key":"10.1002\/14651858.CD014808.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.clinthera.2014.07.017","article-title":"Mechanism of action of colchicine in the treatment of gout","volume":"36","author":"Dalbeth","year":"2014","journal-title":"Clinical Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD014808.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine - update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD014808.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/rheumatology\/kex453","article-title":"Update on colchicine, 2017","volume":"57","author":"Slobodnick","year":"2018","journal-title":"Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD014808.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.ejim.2010.09.010","article-title":"Colchicine in clinical medicine. A guide for internists","volume":"21","author":"Cocco","year":"2010","journal-title":"European Journal of Internal Medicine"},{"issue":"20","key":"10.1002\/14651858.CD014808.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1136\/heartjnl-2020-317108","article-title":"Colchicine for acute and chronic coronary syndromes","volume":"106","author":"Imazio","year":"2020","journal-title":"Heart"},{"issue":"6","key":"10.1002\/14651858.CD014808.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.hlc.2020.11.010","article-title":"The role of colchicine in atherosclerotic cardiovascular disease","volume":"30","author":"Kurup","year":"2021","journal-title":"Heart Lung and Circulation"},{"issue":"9","key":"10.1002\/14651858.CD014808.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2021.07.002","article-title":"Low-dose colchicine for the management of coronary artery disease","volume":"78","author":"Tardif","year":"2021","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD014808.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40256-020-00408-y","article-title":"Inflammation may be the future of cardiovascular risk reduction: does colchicine have a current indication?","volume":"21","year":"2020","journal-title":"American Journal of Cardiovascular Drugs"},{"issue":"11","key":"10.1002\/14651858.CD014808.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.cjca.2020.06.012","article-title":"Will colchicine soon be part of primary and secondary cardiovascular prevention?","volume":"36","author":"Samuel","year":"2020","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vph.2018.09.004","article-title":"Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1","volume":"111","author":"Cimmino","year":"2018","journal-title":"Vascular Pharmacology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2017.03.126","article-title":"Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model","volume":"240","author":"Akodad","year":"2017","journal-title":"International Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD014808.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1253\/circj.CJ-16-0949","article-title":"Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fcvm.2020.631398","article-title":"Anti-inflammatory therapy for coronary atherosclerotic heart disease: unanswered questions behind existing successes","volume":"7","author":"Ma","year":"2021","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"13","key":"10.1002\/14651858.CD014808.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.3390\/jcm10132835","article-title":"Anti-inflammatory drugs in patients with ischemic heart disease","volume":"10","author":"Pello","year":"2021","journal-title":"Journal of Clinical Medicine"},{"issue":"5","key":"10.1002\/14651858.CD014808.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cjca.2020.10.006","article-title":"Colchicine for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Samuel","year":"2021","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0033|cit33","unstructured":"NDA approval (215727); June 2023 Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/appletter\/2023\/215727Orig1s000ltr.pdf"},{"issue":"34","key":"10.1002\/14651858.CD014808.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD014808.pub2-BIB0035|cit35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011047.pub2","article-title":"Colchicine for prevention of cardiovascular events","author":"Hemkens","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0036|cit36","unstructured":"Cumpston M Lasserson T Flemyng E Page MJ Chapter III: Reporting the review (last updated August 2023). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (last updated November 2024). Cochrane, 2024 https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-iii 2023"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD014808.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"CD014808","DOI":"10.1002\/14651858.CD014808","article-title":"Colchicine for the secondary prevention of cardiovascular events (Protocol)","volume":"2023","author":"Ebrahimi","year":"2023","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"h1793","DOI":"10.1136\/bmj.h1793","article-title":"CONSORT extension for reporting N-of-1 trials (CENT) 2015: explanation and elaboration","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0040|cit40","unstructured":"Title 21, Volume 5. Part 312 Subpart B - Investigational new drug application (IND). Sec. 312.32 IND safety reporting Available at https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?CFRPart=312&showFR=1&subpartNode=21:5.0.1.1.3.2"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0041|cit41","unstructured":"How CENTRAL is created; June 2023 Available at https:\/\/www.cochranelibrary.com\/central\/central-creation"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"e078384","DOI":"10.1136\/bmj-2023-078384","article-title":"Guidance on terminology, application, and reporting of citation searching: the TARCiS statement","volume":"385","author":"Hirt","year":"2024","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"k2815","DOI":"10.1136\/bmj.k2815","article-title":"How to use FDA drug approval documents for evidence syntheses","volume":"362","author":"Ladanie","year":"2018","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Systematic Reviews"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0045|cit45","unstructured":"How to create a data extraction template https:\/\/support.covidence.org\/help\/how-to-create-a-data-extraction-template-in-extraction-1 2024"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0046|cit46","unstructured":"Review Manager Web (RevMan Web) The Cochrane Collaboration 2023"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0047|cit47","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0048|cit48","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0049|cit49","unstructured":"Higgins JP Savovic J Page MJ Sterne JA Excel tool to implement RoB 2; August 2019 Available at drive.google.com\/uc?export=download&id=1malyRF_b-DgvAGHssrdt4N9R7Yhljmt0"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0050|cit50","unstructured":"Deeks JJ Higgins JPT Altman DA McKenzie JA Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5 (last updated November 2024). Cochrane, 2024 Available from https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-10"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0051|cit51","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing 'Summary of findings' tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available at https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/archive\/v6.4"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0052|cit52","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2022"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12872-021-02393-9","article-title":"Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial","volume":"21","author":"Akrami","year":"2021","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0054|cit54","unstructured":"Evaluation of the effect of colchicine in the patients with acute coroanry syndrome https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20201117049420N1"},{"issue":"7","key":"10.1002\/14651858.CD014808.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1056\/NEJMoa2405923","article-title":"Routine spironolactone in acute myocardial infarction","volume":"392","author":"Jolly","year":"2024","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.amjcard.2024.02.021","article-title":"SYNERGY-everolimus-eluting stent with a bioabsorbable polymer in ST-elevation myocardial infarction: CLEAR SYNERGY OASIS-9 registry","volume":"220","author":"Jolly","year":"2024","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ahj.2024.06.007","article-title":"Design and rationale of the CLEAR SYNERGY (OASIS 9) trial: a 2x2 factorial randomized controlled trial of colchicine versus placebo and spironolactone vs placebo in patients with myocardial infarction","volume":"275","author":"Lee","year":"2024","journal-title":"American Heart Journal"},{"issue":"10448","key":"10.1002\/14651858.CD014808.pub2-BIB0059|cit59","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(24)00968-1","article-title":"Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial","volume":"404","author":"Kelly","year":"2024","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0060|cit60","unstructured":"The use of colchicine (an anti-inflammatory drug) in prevention of recurrent stroke or heart attack after first stroke; a randomised controlled trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-004505-16-IE"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0061|cit61","unstructured":"The use of colchicine (an anti-inflammatory drug) in prevention of recurrent stroke or heart attack after first stroke; a randomised controlled trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-004505-16-CZ"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.2174\/0115748871325292240904060109","article-title":"Effect of colchicine for prevention of recurrent stroke in ischemic stroke patients with atrial fibrillation: a randomized double-blinded placebo- controlled trial","volume":"Unknown - onlin","author":"Molaeimanesh","year":"2024","journal-title":"Reviews on Recent Clinical Trials"},{"issue":"19","key":"10.1002\/14651858.CD014808.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0064|cit64","unstructured":"Low-dose colchicine for prevention of cardiovascular disease after a cardiovascular event https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-005568-40-NL 2016"},{"issue":"26","key":"10.1002\/14651858.CD014808.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"42","key":"10.1002\/14651858.CD014808.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0067|cit67","unstructured":"Colchicine cardiovascular outcomes trial (COLCOT) https:\/\/clinicaltrials.gov\/show\/NCT02551094 2015"},{"issue":"2","key":"10.1002\/14651858.CD014808.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"e003183","DOI":"10.1161\/CIRCGEN.120.003183","article-title":"Pharmacogenomics of the efficacy and safety of colchicine in COLCOT","volume":"14","author":"Dube","year":"2021","journal-title":"Circulation: Genomic and Precision Medicine"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0069|cit69","unstructured":"Colchicine cardiovascular outcomes trial https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2014-005172-28-PT 2015"},{"issue":"20","key":"10.1002\/14651858.CD014808.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1161\/CIRCULATIONAHA.120.050771","article-title":"Colchicine in patients with acute coronary syndrome: the australian COPS randomized clinical trial","volume":"142","author":"Tong","year":"2020","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0071|cit71","unstructured":"The australian COPS trial - colchicine in patients with acute coronary syndromes http:\/\/www.who.int\/trialsearch\/Trial2.aspx?TrialID=ACTRN12615000861550 2015"},{"issue":"13","key":"10.1002\/14651858.CD014808.pub2-BIB0072|cit72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.124.069808","article-title":"Effect of colchicine on coronary plaque stability in acute coronary syndrome as assessed by optical coherence tomography: the COLOCT randomized clinical trial","volume":"150","author":"Yu","year":"2024","journal-title":"Circulation"},{"issue":"16","key":"10.1002\/14651858.CD014808.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jacc.2013.01.055","article-title":"Colchicine treatment for the prevention of bare-metal stent restenosis in diabetic patients","volume":"61","author":"Deftereos","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD014808.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD014808.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD014808.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/0735-1097(92)90624-v","article-title":"Ineffectiveness of colchicine for the prevention of restenosis after coronary angioplasty","volume":"19","author":"O'Keefe","year":"1992","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0077|cit77","unstructured":"Colchicine for acute coronary syndromes (COACS) https:\/\/clinicaltrials.gov\/study\/NCT01906749 2013"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.ihj.2023.11.043","article-title":"Effects of low dose colchicine in patients of coronary artery disease undergoing percutaneous coronary intervention","volume":"75","author":"Sellakannu","year":"2023","journal-title":"Indian Heart Journal"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0079|cit79","unstructured":"Colchicine use in heart attack patients after percutaneous coronary stenting https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2022\/05\/042760 2022"},{"key":"10.1002\/14651858.CD014808.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2024\/8646351","article-title":"Meta-analysis of randomized trials: efficacy and safety ofcolchicine for secondary prevention of cardiovascular disease","volume":"2024","author":"Akl","year":"2024","journal-title":"Journal of Interventional Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD014808.pub2-BIB0081|cit81","first-page":"618","article-title":"Colchicine in atherosclerotic cardiovascular disease","volume":"110","author":"Tucker","year":"2024","journal-title":"Heart"},{"issue":"28","key":"10.1002\/14651858.CD014808.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD014808.pub2-BIB0083|cit83","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011047","article-title":"Colchicine for prevention of cardiovascular events","author":"Hemkens","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:16:38Z","timestamp":1790140598000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014808.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":83,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014808.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}